PAN-Biotech Panexin NTA Pharma Grade is developed based on the formulation of Panexin NTA (P04-95750). In this xeno-free product, all animal-derived components were replaced by recombinant or human-derived components. Panexin NTA Pharma Grade is a ready-to-use, fully defined serum substitute for the cultivation of adherent cells under serum-free conditions. This sterile product can be used at the standard concentration of 10 % in the cell culture. It supports the adherent growth of many cell types in an optimum manner.
Panexin NTA Pharma Grade contains purified proteins (< 2% w/v), lipids, salts, amino acids, trace elements, attachment factors, hormones and trace of human-derived components (< 2% w/v). Panexin NTA Pharma Grade contains no growth factors, undefined hydrolysates or peptones.
Panexin NTA Pharma Grade is designed to replace or to reduce serum in the cell culture in a very simple manner. There is no need to change the basal medium. It also allows high reproducibility and a simple downstream process. This product contains no growth factors and enables defined proliferation and differentiation of stem cells. Characterization studies of growth factors will obtain more reproducible and conclusive results. Panexin Pharma Grade is also useful to develop sensitive cell-based in vitro tests and co-culture procedures. For cell lines which require specific growth factors these should be added in a concentration as previously used.
Panexin NTA Pharma Grade is suitable for the cultivation of a variety of adherent cells under serum-free culture conditions or to reduce the necessary FBS amount in cell culture.
Storage & Stability
Store: at -20°C, in the dark.
Stability: 2 years from date of production
This product is intended for Laboratory Research Use Only. Not for use in diagnostic or therapeutic procedures. This product may not be used as a pharmaceutical or veterinary drug, agricultural product, or food additive.
FBS replacement, FBS substitute, serum substitute
Ilex Life Sciences LLC is an authorized distributor of PAN-Biotech GmbH.